Session Details
[27P-am]Social pharmacy/Pharmacoepidemiology, Health economics/Pathophysiology (Pathological models, Pharmacological activity, Others)
Thu. Mar 27, 2025 8:30 AM - 12:00 PM JST
Thu. Mar 27, 2025 11:30 PM - 3:00 AM UTC
Thu. Mar 27, 2025 11:30 PM - 3:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[27P-am466]Evaluation of drug-induced bladder toxicity using Transwell-cultured T24 cells.
○Sho Wada1, Kimihiko Urano1, Katsuhiko Matsuura1 (1. Sch. Pharm., Aichi Gakuin Univ.)
[27P-am467]Drug incident management for the future
○Satoshi Tanaka1 (1. Southmiyagi Medical Center)
[27P-am468S]Exploration of Biochemical Pathways Associated with the Onset of Asthma Induced by Non-Steroidal Anti-Inflammatory Drugs Using FAERS
○Katsuma Sato1, Kyosuke Kimura1, Mizuho Asada1, Yosihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am469S]Analysis of Pregnane X Receptor Agonist Activity-Related Adverse Effects Using the FAERS Database
○Saki Yamada1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)
[27P-am470S]Development of a prediction model for identifying drugs associated with pancreatic cancer induction using the FAERS database
○Airi Sasaki1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am471S]Analysis of Biochemical Factors Related to Thromboembolism Induced by Steroid Medications Using the FAERS database
○Ayame Watanabe1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am472S]Comprehensive analysis of NSAIDs inducing drug allergy using the FARES database
○Miu Katagiri1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)
[27P-am473S]Analysis of Cosmetics Associated with Skin Disorders Using the CFSAN Adverse Event Reporting System (CAERS) Database
○Naruki Hanazawa1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharmaceutical Univ.)
[27P-am474S]Comprehensive analysis of sepsis risk induced by anticancer drugs using the FAERS database
○Yui Shirozu1, Mizuho Asada1, Kyosuke Kimura1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am475S]Analysis of drug-induced pancreatitis using the FAERS database
○Honami Abe1, Mizuho Asada1, Kyosuke Kimura1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am476S]Exploration of therapeutic drug candidates based on the pathogenesis analysis of severe cutaneous adverse reactions using FAERS database
○Taichi Nakamura1, Mizuho Asada1, Kyosuke Kimura1, Yoshihiro Uesawa1 (1. Meiji Pharmaceutical Univ)
[27P-am477S]Analysis of biochemical pathways associated with dermatitis Induced by antineoplastic agents using the FAERS database
○Yuzuki Shimano1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am478S]Analysis of causative drugs inducing hematopoietic disorders using FAERS database
○Yuya Kato1, Mizuho Asada1, Kyosuke Kimura1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am479S]Analysis of biochemical factors related to antineoplastic drug-induced erythropenia using the FAERS database
○Akane Shimokawa1, Kyosuke Kimura1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)
[27P-am480S]Analysis of Drugs Associated with the Onset of Cardiac Conduction Disorders Using the FAERS Database
○Takako Yamamoto1, Mizuho Asada1, Kyosuke Kimura1, Yoshihiro Uesawa1 (1. Meiji Pharm. Univ.)
[27P-am481S]The Development of the Operation of “unseiin”in the Field of Dermatology
-The Historical Background of Blood Heat as a Cause of Pruritus in Japanese Kampo medicine-
○Himika Imai1, Tatsuhiko Suzuki1 (1. Faculty of pharmaceutical Sciences, Teikyo Heisei University)
[27P-am482]Quantitative analysis of dabigatran's concentration in human blood using peptide substrate
○Juri Masutomi1, Minsun Park1, Hinako Hatae1, Hiroyuki Kuma1 (1. Dept. Pharm. Sci., Nagasaki International Univ.)
[27P-am483]Development of new assay system for human protein C, a blood coagulant regulator.
○Yuka Okuma1, Ayana Asahi1, Hinako Hatae1, Hiroyuki Kuma1 (1. Dept. Pharm. Sci., Nagasaki International Univ.)
[27P-am484]Examination of expression condition of normal and mutant protein C molecules
○Katsuo Araki1, Yuka Nakata1, Hinako Hatae1, Hiroyuki Kuma1 (1. Dept. Pharm. Sci., Nagasaki International Univ.)
[27P-am485]Risk analysis of postoperative venous thromboembolism by measurement of protein S specific activity.
○Mako Fuchino1, Amin Hirakawa1, Hinako Hatae1, Yasuyuki Abe2, Hiroyuki Kuma1 (1. Dept. Pharm. Sci., Nagasaki International Univ., 2. Kumamoto Chuo Hosp.)
[27P-am486]A questionnaire survey on guidance and support for inhalation of inhaled medications in Fujisawa City
○Motohiko Komai1, Masayuki Miyazawa1, Motoyasu Iilura2, Masanori Nishikawa2, Yasuhiro Kiko1 (1. Fujisawa city hospital department pf pharmacy, 2. Fujisawa city hospital department pf respiratory internal medicine)
[27P-am487]Quantitative Analysis of Pharmaceutical Research in University and Community Hospitals Using Text Mining
○Takaya Suzuki1, Tomoya Sugimoto1, Yukio Toyama1 (1. Toyota Memorial Hospital)
[27P-am488]Analysis of Replies from Community Pharmacists to Survey the Utilization of Medication Management Summary in Psychiatric Patients
○Minako Suenaga1, Shigeru Ishida1, Takahiro Kesamaru1, Mayu Kubota1, Akiko Kanaya1, Rieko Grimm1, Keiko Haraguchi2, Junichi Takaki2, Taro Kihara2, Takeshi Hirota1, Mayako Uchida1 (1. Dept. of Pharmacy, Kyushu Univ. Hosp., 2. Fukuoka City Pharmaceut. Assoc.)
[27P-am489]Questionnaire survey on the "yojokun (precepts for health care) " described in the package inserts of OTC drugs
○Hitoshi Nakamura1, Taisuke Konno1, Hiroyuki Suzuki1, Yuriko Murai1 (1. Fac. Pharm. Sci., Tohoku Med. Pharm. Univ.)
[27P-am490]Development of a non-RI method to measure receptor inhibition constants (Ki) for evaluating drugs with potential anticholinergic effects: Second Report.
○Takeshi Ito1, Takuya Hirao1, Yoshinori Kato1, Hirota Rui1, Wakana Yanachi1, Miho Miyauchi1, Kaito Imamura1, Haruka Yamabe1, Chihiro Tetsuka1, Natsuko Sugiyama1, Harumi Yamada1, Keiji Kuramoto1 (1. Sch. Pharm. Sci., International Univ. Health and Welfare)
[27P-am491]The usefulness of outpatient pharmacist visits for outpatient injections for bone disease treatment drugs revealed through a questionnaire survey of doctors and nurses
○Hiroki Kasai1, Haruko Yuuki1, Chiho Matumoto1, Yoshiyuki Furukawa1, Yoshie Kawanabe1 (1. Sayama General Clinic)
[27P-am492]Survey on the use of antipseudomonal drugs and changes in susceptibility to Pseudomonas aeruginosa
○Daigo Matsumoto1, Hidehiko Semba1, Shodai Higuchi2, Ryo Sakaguchi1, Miyuki Kawata1, Tsugumi Okura1, Akiko Osawa3, Yotaro Takaku4, Tadashi Sannomiya1 (1. Department of Pharmacy, Saitama Cardiovascular and Respiratory Center, 2. Department of Clinical Laboratory, Saitama Cardiovascular and Respiratory Center, 3. The Infection control part, Saitama Cardiovascular and Respiratory Center, 4. Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center)
[27P-am493]The inhibitory effect of dexrazoxane on liposomal doxorubicin-induced hand-foot syndrome-like skin toxicity
○Chihiro Hashimoto1, Rina Mizuno1, Masayuki Tanaka1, Kazuyuki Kitatani1, Kentaro Nishida1 (1. Fac. Pharm. Sci., Setsunan Univ.)
[27P-am494]Effects of strain differences in cyclophosphamide-induced dystrophy model mice
○Mao Ishida1, Mirika Nishino1, Takatoshi Kuga1, Yuya Yoshida1, Takumi Tuji1, Kentaro Nishida1 (1. Fac. Pharm. Sci., Setsunan Univ.)
[27P-am495]Association between serum fatty acid composition and obesity, diabetes, and fatty liver disease, focusing on diet and exercise habits
○Mina Goto1, Kentaro Oniki1, Takao Sato2, Ayami Morita1, Minoru Yoshida3, Junji Saruwatari1 (1. Kumamoto Univ, 2. Kumamoto Industrial Resarch Institute, 3. JRC Kumamoto Health Care Center)
[27P-am496]Study of factors to increase the usage rate of generic drugs in platelet aggregation inhibitors
Takaaki Suzuki1, Mari Iwata2,1, Mika Maezawa1, Kiyoka Matsumoto1, Mizuki Tanaka1, Riko Satake1, Misaki Inoue1, Yu Yoshida1, Kazuhiro Iguchi1, ○Mitsuhiro Nakamura1 (1. Gifu Pharmaceutical University, 2. Yanaizu Pharmacy)
[27P-am497S]Development of a predictive model for brain-to-blood concentration ratios of compounds for the selection of therapeutic agents against bacterial meningitis
○Takuya Ohsugi1, Yuma Iwashita1, Kenji Okada2, Yoshihiro Uesawa1 (1. Meiji Pharmaceutical University, 2. Yokohama University of Pharmacy)
[27P-am498S]Evaluation of metabolic enzyme activity by a novel tryptophan derivative: rat in vivo microdialysis study
○Mai Yamaguchi1, Reika Aoki1, Mayu Onozato1, Tomoya Takaura1, Honoka Fujimoto1, Tatsuya Sakamoto1, Takeshi Fukushima1 (1. Pharm. Sci., Toho Univ.)
[27P-am499S]Adverse Events After Five COVID-19 Vaccine Doses and the Effects of Concurrent Influenza Vaccination
○Megumi Kuroiwa1, Marie Suehiro1,2, Takahiro Muro1,2 (1. Pharm. Sci., Nagasaki International Univ., 2. Grad. Sch. Pharm. Sci., Nagasaki International Univ.)
[27P-am500S]Quantification of five tongue colors using diagnostic methods in traditional Japanese Kampo medicine
-Learning support using Tongue Image Analyzing System (TIAS)-
○Yuko Nitto1, Aya Murakami1, Akira Morita2, Monika Suzuki3, Yuki Watanabe4, Toshiya Nakaguchi5, Takao Namiki4,6 (1. Yokohama University of Pharm., 2. Sumida Kampo Recr. Inst., Chiba Univ., 3. Grad. Sch. Sci. Engr., Chiba Univ., 4. Dept. Japanese oriental (kampo) meds., Chiba Univ., 5. Center for Frontier medical Engr., Chiba Univ., 6. International University of Health and Welfare.)
[2P220-281-36][Skipped Number]
[27P-am502S]Expectations of a pharmacy student from a rural area for measures to address the geographic maldistribution of pharmacists.
○Jura Suzuki1, Rika Fujimoto2, Yumi Koyama1 (1. School of Pharmacy, Nihon University, 2. Lady Drugstore)
[27P-am503]Extraction of inhibitors to promoting the use of My Number health insurance cards-Analysis of pharmacy workers' use of the health insurance cards-
○Yumiko Hanada1, Yuka Kondou2, Tomomi Inoue2, Syunji Isiwata2, Takesi Kotake2 (1. FRONTIER CORPORATION, 2. KINDAI UNIVERSITY)
[27P-am504]Differences in Expressions of Forgetting to Take a Drink to Doctors and Pharmacists: A Web-based Survey Using Scenarios
○shigeru oshima1, nanaho Matsushima, momona takahashi, Norimitsu Horii1, Mizue Mutoh1, Naoko Inoue1 (1. Pharm. Sci.Josai Univ.)
[27P-am505]Evaluation of the effectiveness of a community pharmacist intervention program to facilitate safe drug therapy in patients newly prescribed DPP-4 inhibitors
○Ayana Funabashi1,2, Hitoshi Ito3, Mamoru Maeda3, Yoshitaka Hasegawa3, Ryota Tsukioka3, Mitsuko Onda2 (1. AIN PHARMACIEZ INC., 2. Department of Social and Administrative Pharmacy, Faculty of Pharmacy, OMPU., 3. AIN HOLDINGS INC.)
[27P-am506]Investigation of factors related to subjective muscle mass in Japanese older adults
○Kano Ouchi1, Akiko Kanehara1, Junya Kondo1, Ikuko Nojima1, Keisuke Matsuoka1, Kanae Oshima1, Mutumi Yamashita1, Masahiro Yamada1, Hiromi Yamaashi1, Satoshi Hirata1, Hiroshi Onoue1, Narumi Sugihara2 (1. PHARMACY Co.Ltd., 2. Fac. Pharm. & Pharm. Sci., Fukuyama Univ.)
[27P-am507]Examining the effectiveness of the education for pharmacists on reasonable accommodation for patients with intellectual disabilities
○Masaki Shoji1, Rintaro Imafuku2, Mei Mizomoto3, Mitsuko Onda1 (1. Osaka Medical and Pharmaceutical University, 2. Gifu University, 3. SHINTANI Clinic of psychosomatic medicine)
[27P-am508]Oral Health Awareness Survey of Pharmacists and Registered Sellers on Fluoride-Containing Toothpastes and Fluoride Mouthwashes
○Yuko Kobuke1, Hideki Fukuda2, Toshio Kubota1, Fumika Nakashima1, Takayuki Koga1, Yukiko Fujii1, Fumio Soeda1 (1. Daiichi Univ. Pharm., 2. National Institute of Public Health (NIPH))
[27P-am509]Current status and issues of on-site pharmacies in rural areas - Prescription acceptance status
○Fumihiro Ohashi1, Kunihiko Odaira1, Shunsuke Ajiki1 (1. luckybag Inc.)
[27P-am510]Survey on the current status of the Medication Optimization Project conducted by the four parties (Medical Association, Pharmaceutical Association, University, and Government)
○Tsuyoshi Kato1,2,5, Ootuka Seiji2,5, Saitou Yuji2,5, Tanabe Kouitirou2,5, Doi Nobuyuki3,5, Kanno Nobuyuki4,5, Akazawa Manabu4,5 (1. Tokorozawa Jiko Hospital, 2. Tokorozawa City Pharmacists Association, 3. Takasaki University of Health and Welfare, School of Pharmacy, 4. Meiji Pharmaceutical University, 5. Tokorozawa City Health Promotion Collaboration Promotion Council)
[27P-am511]Examining correlations between athlete category and understanding of anti-doping among physical education college students
○Kyosuke Sato1, Kaoru Kigasawa1, Mitsumasa Kaneta1 (1. Yokohama University of Pharmacy)
[27P-am512]Characteristics of patients who use their “family pharmacy” and “family pharmacist”: Based on patient questionnaires on residual medication and medication adherence.
○Mizutani Reiko1, Sato Kyoka1, Toshinari Mitsuoka1, Hidehiko Sakurai1 (1. Hokkaido University of Science)
[27P-am513]Economic burden and catastrophic costs in tuberculosis patients and their households in Thailand
○Sitaporn Youngkong1,2, Phalin Kamolwat3, Phichet Wongrot4, Montarat Thavorncharoensap1,2, Usa Chaikledkaew1,2, Sriprapa Nateniyom3, Petchawan Pungrassami3, Naiyana Praditsitthikorn5, Surakameth Mahasirimongkol6, Jiraphun Jittikoon7, Nobuyuki Nishikiori8, Ines Garcia Baena8, Takuya Yamanaka8,9,10 (1. Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Thailand, 2. Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand, 3. Division of Tuberculosis, Department of Disease Control, Ministry of Public Health, Thailand, 4. Faculty of Nursing, Mahidol University, Thailand, 5. Department of Disease Control, Ministry of Public Health, Thailand, 6. Department of Medical Sciences, Ministry of Public Health, Thailand, 7. Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Thailand, 8. World Health Organization Global Tuberculosis Programme, Geneva, Switzerland, 9. Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK, 10. School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan)
[27P-am514]Evaluation of the association between antiretroviral drugs and cardiovascular events: Signal detection using spontaneous reporting database
○Shigeru Hasebe1, Shiori Iwane1, Masayuki Tanaka1, Toshikazu Tuji1, Maho Kikuta1 (1. Fac. Pharm. Sci., Setsunan Univ.)
[27P-am515S]The risk of subsequent fractures in patients treated for hip fracture using a Japanese large claims data
○Tsubasa Hochido1, Yuto Kasai2, Ryo Kitsu1, Takumi Miyoshi1, Ryosuke Kumazawa1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical University, 2. Higashikawaguchi Hospital)
[27P-am516S]Survey on factors influencing renal function decline with chronic kidney disease using medical big data
○Mikoto Suzuki1, Koji Sato1, Yoshiko Tominaga1, Toshiyuki Sakamaki1 (1. Fuc. Pharm., NUPMLS)
[27P-am517]Increasing incidence of suicide in Japan after COVID-19 pandemic: Analysis by region and suicide means
○Kazuki Nagashima1, Yoshiki Sugiyama1, Yuko Sekine1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
[27P-am518S]Development of a scale for measuring the ease of working as a pharmacist in pharmacies
○Aoi Yamaguchi1, Hikaru Izumi1, Nana Suzuki1, Toshinari Mitsuoka1 (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science)
[27P-am521S]Effect of azilsartan on TNF-α expression induced by glucose and palmitic acid in R28 cells
○Ryushi Hoshino1, Mami Terada, Kohsuke Hayamizu, Akihide Sumino (1. Yokohama University of Pharmacy)
[27P-am519]Creation of a model animal for radiation-induced intestinal damage
○Yukiro Kurokawa1,2, Shinichi Watanabe2, Noriaki Hidaka1, Mamoru Tanaka1 (1. Div. Pharm., Ehime Univ. Hosp., 2. Grad. Sch. Pharm. Sci., Matsuyama Univ.)
[27P-am520]Generation of TDP-43 accumulation model mice by adeno-associated virus expression system
○Naomi Nihonmatsu1, Takashi Nonaka1, Mina Takase1, Reiko Ohtani1, Masami Suzukake 1, Shotaro Shimonaka1, Genjiro Suzuki1, Shinichi Hisanaga1, Airi Tarutani 1, Fuyuki Kametani1, Masato Hasegawa1 (1. Tokyo Metropolitan Institute of Medical Sci.)
[27P-am522S]Effect of ZIP13 point mutation in patients with EDSSPD3 on osteoblast differentiation: Study using patient iPS cells and gene-repaired iPS cells.
○Fuka Nagabuchi1, Masaki Shoji1, Saki Nagase1, Haato Yuri1, Takafumi Hara2, Emi Yoshigai2, Ayako Fukunaka3, Ayu Matsunaga4, Yuki Hirakawa5, Keiko Momma5, Hiroshi Narita5, Yoshio Fujitani3, Heloísa G. dos Santos6, Toshiyuki Fukada2, Takashi Kuzuhara1 (1. Lab. of Biochem., Facul. of Pharm. Sci., Tokushima Bunri Univ. , 2. Dep. of Mol. and Cellular Physiol., Facul. of Pharm. Sci., Tokushima Bunri Univ., 3. Lab. of Dev. Bio. and Metabo., Inst. for Mol. and Cellular Reg., Gunma Univ., 4. Dep. of Appl. Biol. Sci., Takasaki Univ. of Heal. and Wel., 5. Dep. of Food and Nut., Kyoto Women’s Univ., 6. Serviço Genética Médica, Hospital S. Maria.)
[27P-am523]The effects of patchouli essential oil inhalation on hyperactivity and impulsivity in childhood mice model with attention deficit/hyperactivity disorder
○Saika Iwahashi1, Yusuke Murata1, Ayumi Maehama1, Masayoshi Mori1, Munechika Enjoji1 (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ)
[27P-am524]The beneficial effects of aromatherapy on motor performance impairment and emotional dysregulation in mice model with alcohol hangover
○Reika Sakai1, Yusuke Murata1, Masayoshi Mori1, Munechika Enjoji1 (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ.)
[27P-am525]Chronic inhalation of peppermint essential oil affects the brain molecular physiology of mice model with atopic dermatitis
○Yuka Chijiiwa1, Yusuke Murata1, Shotaro Shoji1, Rei Araki1, Mai Murata1, Masayoshi Mori1, Munechika Enjoji1 (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ.)
[27P-am526]The ameliorating effect of grapefruit essential oil inhalation on stress-induced emotional eating in female mice
○Rina Manabe1, Yusuke Murata1, Masayoshi Mori1, Munechika Enjoji1 (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ.)
[27P-am527]Search for mast cell activation inhibitors using chimeric IgE receptor-expressing cell line HuRa-40
○Chisato Kurisaka1, Tomoki Oyama1, Chiho Murao1, Yuuho Aizawa1, Yuuka Iwata1, Ryosuke Nakamura2, Haruyo Akiyama1 (1. Fac. Pharm. Sci., Teikyo Heisei Univ., 2. Fac. Pharm. Sci., Teikyo Univ.)